How RiverNorth RMMZ responds to market challenges 033 20260511 Bristol Myers Squibb BMY Vertex Pharmaceuticals VRTX Poised for Upside From Partner CRISPR Therapeutics 2026 Clinical Catalysts MYE Myers Industries posts 33 percent Q4 2025 EPS beat yet shares dip 131 percent in todays trading How Coll Mining CNL is investing for future growth Q4 2025 EPS Misses Estimates FLD Q1 2026 Earnings Significant EPS Miss Sends Stock Lower VICR Q1 2026 Earnings EPS Surprises 1983 Above Estimates as Stock Declines Slightly JOBY Q1 2026 Earnings EPS Beat Narrowing Losses as eVTOL Development Progresses Arbor Realty Trust ABR Q1 2026 Earnings Earnings Miss by Wide Margin as EPS Falls 40 Below Estimates TSM Q1 2026 Earnings EPS Surges Past Estimates Driven by AI Chip Demand ELVA Q1 2026 Earnings EPS Surprises to the Upside Stock Rises Over 7